Heteromers of μ opioid and dopamine D 1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner
Exposure to opiates induces locomotor sensitization in rodents, which has been proposed to correspond to the compulsive drug-seeking behaviour. Numerous studies have demonstrated that locomotor sensitization can occur in a dopamine transmission-independent manner; however, the underlying mechanisms...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 2017-09, Vol.174 (17), p.2842-2861 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2861 |
---|---|
container_issue | 17 |
container_start_page | 2842 |
container_title | British journal of pharmacology |
container_volume | 174 |
creator | Tao, Yi-Min Yu, Chuan Wang, Wei-Sheng Hou, Yuan-Yuan Xu, Xue-Jun Chi, Zhi-Qiang Ding, Yu-Qiang Wang, Yu-Jun Liu, Jing-Gen |
description | Exposure to opiates induces locomotor sensitization in rodents, which has been proposed to correspond to the compulsive drug-seeking behaviour. Numerous studies have demonstrated that locomotor sensitization can occur in a dopamine transmission-independent manner; however, the underlying mechanisms are unclear.
Co-immunoprecipitation, BRET and cross-antagonism assays were used to demonstrate the existence of receptor heterodimers. Function of heterodimers was evaluated by behavioural studies of locomotor sensitization.
The dopamine D
receptor antagonist SCH23390 antagonized the signalling initiated by stimulation of μ opioid receptors with agonists in transfected cells expressing two receptors and in striatal tissues from wild-type but not D
receptor knockout (KO) mice, suggesting that SCH23390 modified μ receptor function via receptor heteromers, as the ability of an antagonist of one of the receptors to inhibit signals originated by stimulation of the partner receptor was a characteristic of receptor heteromers. The existence of μ receptor-D
receptor heterodimers was further supported by biochemical and biophysical assays. In vivo, when dopamine release was absent (by destruction of the dopaminergic projection from the ventral tegmental area to the striatum), SCH23390 still significantly inhibited μ receptor agonist-induced behavioural responses in rats. Additionally, we demonstrated that D
or μ receptor KO mice and thus unable to form μ receptor-D
receptor heterodimers, failed to show locomotor sensitization to morphine.
Our results suggest that μ receptor-D
receptor heterodimers may be involved in the dopamine-independent expression of locomotor sensitization to opiates. |
doi_str_mv | 10.1111/bph.13908 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_bph_13908</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>28608532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c972-350dbd71dfa892acf2b68aa6d4d24aebd487da612f9fb3143c53016105ed90543</originalsourceid><addsrcrecordid>eNo90L9OwzAQBnALgWgpDLwA8sqQYsdx4oyo_ClSJZbukZO7CKPajux0gJXX4hl4JlxaesPdcD99w0fINWdznuauHd7mXNRMnZApL6oyk0LxUzJljFUZ50pNyEWM74ylZyXPySRXJVNS5FPytcQRg7cYIvU9_fmmfjDeANUOKPhBW-OQPlBOA3Y4jD4562G70SMeaGYcbDsEuvGdtz4RGtFFM5pPPRrvqHFUH7N2GgdMy43UaucwXJKzXm8iXh3ujKyfHteLZbZ6fX5Z3K-yrq7yTEgGLVQceq3qXHd93pZK6xIKyAuNLRSqAl3yvK_7VvBCdFIwXnImEWomCzEjt_vYLvgYA_bNEIzV4aPhrNn12KQem78ek73Z22HbWoSj_C9O_AKXsHGm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Heteromers of μ opioid and dopamine D 1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Tao, Yi-Min ; Yu, Chuan ; Wang, Wei-Sheng ; Hou, Yuan-Yuan ; Xu, Xue-Jun ; Chi, Zhi-Qiang ; Ding, Yu-Qiang ; Wang, Yu-Jun ; Liu, Jing-Gen</creator><creatorcontrib>Tao, Yi-Min ; Yu, Chuan ; Wang, Wei-Sheng ; Hou, Yuan-Yuan ; Xu, Xue-Jun ; Chi, Zhi-Qiang ; Ding, Yu-Qiang ; Wang, Yu-Jun ; Liu, Jing-Gen</creatorcontrib><description>Exposure to opiates induces locomotor sensitization in rodents, which has been proposed to correspond to the compulsive drug-seeking behaviour. Numerous studies have demonstrated that locomotor sensitization can occur in a dopamine transmission-independent manner; however, the underlying mechanisms are unclear.
Co-immunoprecipitation, BRET and cross-antagonism assays were used to demonstrate the existence of receptor heterodimers. Function of heterodimers was evaluated by behavioural studies of locomotor sensitization.
The dopamine D
receptor antagonist SCH23390 antagonized the signalling initiated by stimulation of μ opioid receptors with agonists in transfected cells expressing two receptors and in striatal tissues from wild-type but not D
receptor knockout (KO) mice, suggesting that SCH23390 modified μ receptor function via receptor heteromers, as the ability of an antagonist of one of the receptors to inhibit signals originated by stimulation of the partner receptor was a characteristic of receptor heteromers. The existence of μ receptor-D
receptor heterodimers was further supported by biochemical and biophysical assays. In vivo, when dopamine release was absent (by destruction of the dopaminergic projection from the ventral tegmental area to the striatum), SCH23390 still significantly inhibited μ receptor agonist-induced behavioural responses in rats. Additionally, we demonstrated that D
or μ receptor KO mice and thus unable to form μ receptor-D
receptor heterodimers, failed to show locomotor sensitization to morphine.
Our results suggest that μ receptor-D
receptor heterodimers may be involved in the dopamine-independent expression of locomotor sensitization to opiates.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.13908</identifier><identifier>PMID: 28608532</identifier><language>eng</language><publisher>England</publisher><subject>Analgesics, Opioid - pharmacology ; Animals ; Benzazepines - pharmacology ; Cells, Cultured ; Cyclic AMP - metabolism ; Dopamine ; Dopamine Antagonists - pharmacology ; Extracellular Signal-Regulated MAP Kinases - metabolism ; Guanosine 5'-O-(3-Thiotriphosphate) - metabolism ; HEK293 Cells ; Humans ; Mice, Knockout ; Motor Activity - drug effects ; Neurons - drug effects ; Neurons - metabolism ; Proto-Oncogene Proteins c-fos - metabolism ; Rats, Sprague-Dawley ; Receptors, Dopamine D1 - genetics ; Receptors, Dopamine D1 - metabolism ; Receptors, Opioid, mu - metabolism</subject><ispartof>British journal of pharmacology, 2017-09, Vol.174 (17), p.2842-2861</ispartof><rights>2017 The British Pharmacological Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c972-350dbd71dfa892acf2b68aa6d4d24aebd487da612f9fb3143c53016105ed90543</citedby><cites>FETCH-LOGICAL-c972-350dbd71dfa892acf2b68aa6d4d24aebd487da612f9fb3143c53016105ed90543</cites><orcidid>0000-0002-2869-0029</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28608532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tao, Yi-Min</creatorcontrib><creatorcontrib>Yu, Chuan</creatorcontrib><creatorcontrib>Wang, Wei-Sheng</creatorcontrib><creatorcontrib>Hou, Yuan-Yuan</creatorcontrib><creatorcontrib>Xu, Xue-Jun</creatorcontrib><creatorcontrib>Chi, Zhi-Qiang</creatorcontrib><creatorcontrib>Ding, Yu-Qiang</creatorcontrib><creatorcontrib>Wang, Yu-Jun</creatorcontrib><creatorcontrib>Liu, Jing-Gen</creatorcontrib><title>Heteromers of μ opioid and dopamine D 1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Exposure to opiates induces locomotor sensitization in rodents, which has been proposed to correspond to the compulsive drug-seeking behaviour. Numerous studies have demonstrated that locomotor sensitization can occur in a dopamine transmission-independent manner; however, the underlying mechanisms are unclear.
Co-immunoprecipitation, BRET and cross-antagonism assays were used to demonstrate the existence of receptor heterodimers. Function of heterodimers was evaluated by behavioural studies of locomotor sensitization.
The dopamine D
receptor antagonist SCH23390 antagonized the signalling initiated by stimulation of μ opioid receptors with agonists in transfected cells expressing two receptors and in striatal tissues from wild-type but not D
receptor knockout (KO) mice, suggesting that SCH23390 modified μ receptor function via receptor heteromers, as the ability of an antagonist of one of the receptors to inhibit signals originated by stimulation of the partner receptor was a characteristic of receptor heteromers. The existence of μ receptor-D
receptor heterodimers was further supported by biochemical and biophysical assays. In vivo, when dopamine release was absent (by destruction of the dopaminergic projection from the ventral tegmental area to the striatum), SCH23390 still significantly inhibited μ receptor agonist-induced behavioural responses in rats. Additionally, we demonstrated that D
or μ receptor KO mice and thus unable to form μ receptor-D
receptor heterodimers, failed to show locomotor sensitization to morphine.
Our results suggest that μ receptor-D
receptor heterodimers may be involved in the dopamine-independent expression of locomotor sensitization to opiates.</description><subject>Analgesics, Opioid - pharmacology</subject><subject>Animals</subject><subject>Benzazepines - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cyclic AMP - metabolism</subject><subject>Dopamine</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>Guanosine 5'-O-(3-Thiotriphosphate) - metabolism</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Mice, Knockout</subject><subject>Motor Activity - drug effects</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Proto-Oncogene Proteins c-fos - metabolism</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Dopamine D1 - genetics</subject><subject>Receptors, Dopamine D1 - metabolism</subject><subject>Receptors, Opioid, mu - metabolism</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90L9OwzAQBnALgWgpDLwA8sqQYsdx4oyo_ClSJZbukZO7CKPajux0gJXX4hl4JlxaesPdcD99w0fINWdznuauHd7mXNRMnZApL6oyk0LxUzJljFUZ50pNyEWM74ylZyXPySRXJVNS5FPytcQRg7cYIvU9_fmmfjDeANUOKPhBW-OQPlBOA3Y4jD4562G70SMeaGYcbDsEuvGdtz4RGtFFM5pPPRrvqHFUH7N2GgdMy43UaucwXJKzXm8iXh3ujKyfHteLZbZ6fX5Z3K-yrq7yTEgGLVQceq3qXHd93pZK6xIKyAuNLRSqAl3yvK_7VvBCdFIwXnImEWomCzEjt_vYLvgYA_bNEIzV4aPhrNn12KQem78ek73Z22HbWoSj_C9O_AKXsHGm</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Tao, Yi-Min</creator><creator>Yu, Chuan</creator><creator>Wang, Wei-Sheng</creator><creator>Hou, Yuan-Yuan</creator><creator>Xu, Xue-Jun</creator><creator>Chi, Zhi-Qiang</creator><creator>Ding, Yu-Qiang</creator><creator>Wang, Yu-Jun</creator><creator>Liu, Jing-Gen</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-2869-0029</orcidid></search><sort><creationdate>201709</creationdate><title>Heteromers of μ opioid and dopamine D 1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner</title><author>Tao, Yi-Min ; Yu, Chuan ; Wang, Wei-Sheng ; Hou, Yuan-Yuan ; Xu, Xue-Jun ; Chi, Zhi-Qiang ; Ding, Yu-Qiang ; Wang, Yu-Jun ; Liu, Jing-Gen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c972-350dbd71dfa892acf2b68aa6d4d24aebd487da612f9fb3143c53016105ed90543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Analgesics, Opioid - pharmacology</topic><topic>Animals</topic><topic>Benzazepines - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cyclic AMP - metabolism</topic><topic>Dopamine</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>Guanosine 5'-O-(3-Thiotriphosphate) - metabolism</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Mice, Knockout</topic><topic>Motor Activity - drug effects</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Proto-Oncogene Proteins c-fos - metabolism</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Dopamine D1 - genetics</topic><topic>Receptors, Dopamine D1 - metabolism</topic><topic>Receptors, Opioid, mu - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tao, Yi-Min</creatorcontrib><creatorcontrib>Yu, Chuan</creatorcontrib><creatorcontrib>Wang, Wei-Sheng</creatorcontrib><creatorcontrib>Hou, Yuan-Yuan</creatorcontrib><creatorcontrib>Xu, Xue-Jun</creatorcontrib><creatorcontrib>Chi, Zhi-Qiang</creatorcontrib><creatorcontrib>Ding, Yu-Qiang</creatorcontrib><creatorcontrib>Wang, Yu-Jun</creatorcontrib><creatorcontrib>Liu, Jing-Gen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tao, Yi-Min</au><au>Yu, Chuan</au><au>Wang, Wei-Sheng</au><au>Hou, Yuan-Yuan</au><au>Xu, Xue-Jun</au><au>Chi, Zhi-Qiang</au><au>Ding, Yu-Qiang</au><au>Wang, Yu-Jun</au><au>Liu, Jing-Gen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heteromers of μ opioid and dopamine D 1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2017-09</date><risdate>2017</risdate><volume>174</volume><issue>17</issue><spage>2842</spage><epage>2861</epage><pages>2842-2861</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Exposure to opiates induces locomotor sensitization in rodents, which has been proposed to correspond to the compulsive drug-seeking behaviour. Numerous studies have demonstrated that locomotor sensitization can occur in a dopamine transmission-independent manner; however, the underlying mechanisms are unclear.
Co-immunoprecipitation, BRET and cross-antagonism assays were used to demonstrate the existence of receptor heterodimers. Function of heterodimers was evaluated by behavioural studies of locomotor sensitization.
The dopamine D
receptor antagonist SCH23390 antagonized the signalling initiated by stimulation of μ opioid receptors with agonists in transfected cells expressing two receptors and in striatal tissues from wild-type but not D
receptor knockout (KO) mice, suggesting that SCH23390 modified μ receptor function via receptor heteromers, as the ability of an antagonist of one of the receptors to inhibit signals originated by stimulation of the partner receptor was a characteristic of receptor heteromers. The existence of μ receptor-D
receptor heterodimers was further supported by biochemical and biophysical assays. In vivo, when dopamine release was absent (by destruction of the dopaminergic projection from the ventral tegmental area to the striatum), SCH23390 still significantly inhibited μ receptor agonist-induced behavioural responses in rats. Additionally, we demonstrated that D
or μ receptor KO mice and thus unable to form μ receptor-D
receptor heterodimers, failed to show locomotor sensitization to morphine.
Our results suggest that μ receptor-D
receptor heterodimers may be involved in the dopamine-independent expression of locomotor sensitization to opiates.</abstract><cop>England</cop><pmid>28608532</pmid><doi>10.1111/bph.13908</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0002-2869-0029</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2017-09, Vol.174 (17), p.2842-2861 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_crossref_primary_10_1111_bph_13908 |
source | MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
subjects | Analgesics, Opioid - pharmacology Animals Benzazepines - pharmacology Cells, Cultured Cyclic AMP - metabolism Dopamine Dopamine Antagonists - pharmacology Extracellular Signal-Regulated MAP Kinases - metabolism Guanosine 5'-O-(3-Thiotriphosphate) - metabolism HEK293 Cells Humans Mice, Knockout Motor Activity - drug effects Neurons - drug effects Neurons - metabolism Proto-Oncogene Proteins c-fos - metabolism Rats, Sprague-Dawley Receptors, Dopamine D1 - genetics Receptors, Dopamine D1 - metabolism Receptors, Opioid, mu - metabolism |
title | Heteromers of μ opioid and dopamine D 1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T05%3A41%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heteromers%20of%20%CE%BC%20opioid%20and%20dopamine%20D%201%20receptors%20modulate%20opioid-induced%20locomotor%20sensitization%20in%20a%20dopamine-independent%20manner&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Tao,%20Yi-Min&rft.date=2017-09&rft.volume=174&rft.issue=17&rft.spage=2842&rft.epage=2861&rft.pages=2842-2861&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.13908&rft_dat=%3Cpubmed_cross%3E28608532%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28608532&rfr_iscdi=true |